The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study

Elisa De Franco; Sarah E. Flanagan; Jayne Houghton; Hana Lango Allen; Deborah Mackay; I. Karen Temple; Sian Ellard; Andrew T. Hattersley

doi:10.1016/s0140-6736(15)60098-8

July 29, 2015The LancetOpen Access

The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study

View Full Paper

Ask AI

Bookmark

Share

Key Points

To assess how early and comprehensive genomic testing influences clinical management and outcomes in individuals diagnosed with neonatal diabetes.
International cohort study analyzing patients presenting with neonatal diabetes who received early, comprehensive genomic sequencing.
Early genomic testing provides rapid molecular diagnoses that guide targeted treatment strategies and inform ongoing clinical care in neonatal diabetes.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

International cohort study reveals the impact of early comprehensive genomic testing on clinical care in neonatal diabetes, highlighting the role of precision medicine.

Abstract

Wellcome Trust and Diabetes UK.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Franco et al. (2015) studied this question.

synapsesocial.com/papers/69dd52158557d5ab8f40ce6b https://doi.org/10.1016/s0140-6736(15)60098-8

View Full Paper

Ask AI

Bookmark

Share

The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading